Fn14-targeted BiTE and CAR-T cells demonstrate potent preclinical activity against glioblastoma.
Li G, Zhang Z, Cai L, Tang X, Huang J, Yu L, Wang G, Zhong K, Cao Y, Liu C, Wang Y, Tong A, Zhou L.
Li G, et al. Among authors: cao y.
Oncoimmunology. 2021 Sep 27;10(1):1983306. doi: 10.1080/2162402X.2021.1983306. eCollection 2021.
Oncoimmunology. 2021.
PMID: 34595061
Free PMC article.